These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 17154643)

  • 1. A review of calcium channel antagonists in the treatment of pediatric hypertension.
    Sahney S
    Paediatr Drugs; 2006; 8(6):357-73. PubMed ID: 17154643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the role of calcium channel antagonists in heart failure due to systolic dysfunction.
    Mahé I; Chassany O; Grenard AS; Caulin C; Bergmann JF
    Am J Cardiovasc Drugs; 2003; 3(1):33-41. PubMed ID: 14727944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.
    Opie LH
    Cardiovasc Drugs Ther; 1988 Mar; 1(6):625-56. PubMed ID: 3154329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lercanidipine : a review of its efficacy in the management of hypertension.
    Bang LM; Chapman TM; Goa KL
    Drugs; 2003; 63(22):2449-72. PubMed ID: 14609358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers: pharmacology and place in therapy of pediatric hypertension.
    Flynn JT; Pasko DA
    Pediatr Nephrol; 2000 Dec; 15(3-4):302-16. PubMed ID: 11149130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What, if anything, is controversial about calcium antagonists?
    Messerli FH
    Am J Hypertens; 1996 Dec; 9(12 Pt 2):177S-181S. PubMed ID: 8968430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Felodipine and isradipine: new calcium-channel-blocking agents for the treatment of hypertension.
    Walton T; Symes LR
    Clin Pharm; 1993 Apr; 12(4):261-75. PubMed ID: 8458178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial experience with isradipine for the treatment of hypertension in children.
    Strauser LM; Groshong T; Tobias JD
    South Med J; 2000 Mar; 93(3):287-93. PubMed ID: 10728516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational use of calcium-channel antagonists in Raynaud's phenomenon.
    Sturgill MG; Seibold JR
    Curr Opin Rheumatol; 1998 Nov; 10(6):584-8. PubMed ID: 9812220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized prospective crossover trial of amlodipine in pediatric hypertension.
    Rogan JW; Lyszkiewicz DA; Blowey D; Khattak S; Arbus GS; Koren G
    Pediatr Nephrol; 2000 Oct; 14(12):1083-7. PubMed ID: 11045391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the safety of short-acting nifedipine in children with hypertension.
    Egger DW; Deming DD; Hamada N; Perkin RM; Sahney S
    Pediatr Nephrol; 2002 Jan; 17(1):35-40. PubMed ID: 11793132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of calcium channel antagonists for cardiovascular disease.
    Yedinak KC
    Am Pharm; 1993 Aug; NS33(8):49-64; quiz 64-6. PubMed ID: 8213473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive activity of a new calcium channel blocker LF 2.0254, in spontaneously hypertensive rats: a comparison with nifedipine and nicardipine.
    Pruneau D; Brown NL
    Arch Int Pharmacodyn Ther; 1988; 295():109-24. PubMed ID: 2977540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats.
    Karasawa A; Kubo K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isradipine treatment of hypertension in children: a single-center experience.
    Flynn JT; Warnick SJ
    Pediatr Nephrol; 2002 Sep; 17(9):748-53. PubMed ID: 12215829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Felodipine/metoprolol: a review of the fixed dose controlled release formulation in the management of essential hypertension.
    Haria M; Plosker GL; Markham A
    Drugs; 2000 Jan; 59(1):141-57. PubMed ID: 10718104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.